Orchard Therapeutics PLC Sponsored ADR Debt to Equity Ratio 2019-2023 | ORTX
Current and historical debt to equity ratio values for Orchard Therapeutics PLC Sponsored ADR (ORTX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Orchard Therapeutics PLC Sponsored ADR debt/equity for the three months ending September 30, 2023 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2023-09-30 | $0.12B | $0.08B | 1.52 |
| 2023-06-30 | $0.12B | $0.11B | 1.13 |
| 2023-03-31 | $0.12B | $0.10B | 1.14 |
| 2022-12-31 | $0.12B | $0.10B | 1.23 |
| 2022-09-30 | $0.11B | $0.12B | 0.89 |
| 2022-06-30 | $0.11B | $0.15B | 0.77 |
| 2022-03-31 | $0.12B | $0.18B | 0.66 |
| 2021-12-31 | $0.11B | $0.21B | 0.54 |
| 2021-09-30 | $0.11B | $0.24B | 0.47 |
| 2021-06-30 | $0.10B | $0.26B | 0.38 |
| 2021-03-31 | $0.09B | $0.30B | 0.32 |
| 2020-12-31 | $0.10B | $0.18B | 0.57 |
| 2020-09-30 | $0.09B | $0.21B | 0.44 |
| 2020-06-30 | $0.09B | $0.23B | 0.39 |
| 2020-03-31 | $0.09B | $0.27B | 0.34 |
| 2019-12-31 | $0.10B | $0.30B | 0.34 |
| 2019-09-30 | $0.08B | $0.34B | 0.22 |
| 2019-06-30 | $0.09B | $0.37B | 0.23 |
| 2019-03-31 | $0.04B | $0.29B | 0.15 |
| 2018-12-31 | $0.06B | $0.31B | 0.18 |
| 2018-09-30 | $0.00B | 0.00 | |
| 2018-06-30 | $0.00B | 0.00 | |
| 2018-03-31 | $0.00B | 0.00 | |
